Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Shiyi Shao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3410-9058; OpenAlex author ID A5102331937. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 7

  1. Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer. Co-author DOI 10.1002/advs.76135↗
  2. STING-activating pyroptotic nanoparticles for in situ pancreatic cancer vaccination and immunotherapy. Co-author DOI 10.1016/j.scib.2025.04.015↗
  3. Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy. Co-author DOI 10.1186/s12951-024-03033-y↗
  4. In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/adhm.202203264↗
  5. An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer. Co-author DOI 10.1002/advs.202206756↗
  6. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer. Co-author DOI 10.1002/advs.202202914↗
  7. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy. Co-author DOI 10.1186/s12951-022-01282-3↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qida Hu · 6 shared papers, 2022–2026 · strength 1.30
  2. Tingbo Liang · 4 shared papers, 2022–2025 · strength 0.85
  3. Meng Wang · 3 shared papers, 2022–2025 · strength 0.59
  4. Tingbo Liang · 2 shared papers, 2022–2026 · strength 0.43
  5. Junming Huang · 2 shared papers, 2023 · strength 0.39
  6. Junming Huang · 1 shared paper, 2026 · strength 0.27
  7. Xiazhen Yu · 1 shared paper, 2025 · strength 0.23
  8. Meng Wang · 1 shared paper, 2023 · strength 0.19
  9. Tingbo Liang · 1 shared paper, 2023 · strength 0.19
  10. Xingang Liu · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.